A multi-institutional team has developed a deep learning framework to identify novel molecules as drug candidates.

PNNL scientists partnered with colleagues at the University of Akron to create a new molecule that could substantially improve the electrochemical stability of redox flow batteries.

A multi-institutional team has obtained information about nanoscale interactions between the spike protein of the novel coronavirus SARS-CoV-2 and common household inorganic surfaces.

The Energy Storage for Social Equity Initiative will help up to 15 disadvantaged communities consider energy storage technologies to meet local energy goals.

Electrical engineer Aditya Ashok and cybersecurity researcher Thomas Edgar win best paper award for their work to create a new high-fidelity dataset that will help advance cybersecurity solutions for critical infrastructure protection.

Scientists have devised a way to engineer yeast to produce sustainable, eco-friendly commodity chemicals using computing power as a guide.

Researchers map nearly 9,000 proteins in the human lungs, providing a clearer picture of development.

The nested nanoPOTS chip is the next generation of technology developed at PNNL to prepare single cells for proteomics.

Customized molecular tools identify specific microbial functions that are key to healthy people and environments.

A study of Middle East Respiratory Syndrome has identified a compound that shows potential in easing the symptoms of coronavirus infections.

PNNL’s new Energy Sciences Center has capabilities for scientists to advance solutions for storing clean hydrogen in chemical bonds.

PNNL has received 119 R&D 100 Awards since 1969, when the laboratory began submitting entries in the contest that recognizes top 100 inventions each year.

Mary Lancaster, epidemiologist and data scientist, co-authored a chapter on cyberbiosecurity for the NATO Science for Peace and Security book series.

Exposure to polycyclic aromatic hydrocarbons found at Superfund Sites induces enzymes in dose- and time-dependent patterns in mice.

PNNL data scientists are refining their artificial intelligence tools with COVID-19 data to advance therapeutics and treatments for a future pandemic.

Science and engineering solutions helping keep America safe from explosive, radiological, biological and cyber threats.

A comprehensive literature review linking algae and antivirals determines compounds in algae may demonstrate an exceptional—and as yet untapped—potential to combat viral diseases at every point along the viral infection pathway.

PNNL commemorates 9/11 and reflects on the 20 years of science and technology produced since to protect against threats and make America safer.

For postdoctoral researcher Kari Gaither, sharing science with students is a personal and professional commitment.

Nanobiologist Brian Thrall retires after a 30-year career in nanotoxicology research, advisory roles for federal sponsors, and management.